FIELD: medicine; biotechnology.
SUBSTANCE: disclosed is use of a dumbbell-shaped linear, covalently closed DNA expression construct with a double-stranded stem and single-stranded loops located at both ends of stem, wherein stem of complementary deoxyribonucleic acids of a circular DNA strand comprises a promotor sequence, a coding sequence and a termination signal, where DNA construct codes TNF-α, for treating melanoma, wherein said DNA construct is administered by jet injection, and said construct is administered simultaneously or successively with vindesine.
EFFECT: use of said DNA construct significantly enhances vindesine action.
5 cl, 7 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
ALLOGENEIC ANTITUMOR THERAPEUTIC MEDICATION | 2004 |
|
RU2354694C2 |
DNA CONSTRUCT FOR EXPRESSION | 2011 |
|
RU2604186C2 |
METHOD AND COMPOSITION FOR DIAGNOSING AND TREATING CANCER | 1996 |
|
RU2174409C2 |
SPARC-BINDING PEPTIDES AND USING THEM | 2009 |
|
RU2491085C2 |
MULTIPURPOSE CANCER-SPECIFIC PROMOTERS AND USING THEM IN ANTI-CANCER THERAPY | 2013 |
|
RU2539764C2 |
POLYCONJUGATES FOR POLYNUCLEOTIDE INTRODUCTION IN VIVO | 2007 |
|
RU2430740C2 |
MICROVESICLE AND METHOD FOR ITS PREPARATION | 2014 |
|
RU2693088C2 |
ACTIVE ANGIOGENESIS-PREVENTING IMMUNETHERAPY | 2003 |
|
RU2329824C2 |
RECEPTORS-MEDIATED DELIVERY OF GENES BY USING VECTORS BASED UPON BACTERIOPHAGES | 1998 |
|
RU2209088C2 |
DNA ENCODING NEW RGI PEPTIDE | 2000 |
|
RU2283130C2 |
Authors
Dates
2016-09-27—Published
2011-09-08—Filed